Hanoch Rappaport serves as Executive at BIOCANCELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Hanoch Rappaport has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 21, 2010 involved purchasing 17,796 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 21, 2010 | BICL.TA | $0 | Purchase | 17,796 | $N/A | Discretionary |
Hanoch Rappaport currently holds 17,796 shares of BIOCANCELL THERAPEUTICS INC. (BICL.TA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hanoch Rappaport has been a net neutral trader of BICL.TA stock. They have purchased $0 and sold $0 worth of shares.
Hanoch Rappaport's most recent insider trade was on Nov 21, 2010, when they purchased 17,796 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted